HURA Valuation

TuHURA Biosciences Inc

Add to Watchlist

Advanced Chart

2.680

-0.1(-3.597%)1D

Overview
Forecast
Valuation
Earnings

HURA Relative Valuation

HURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HURA is overvalued; if below, it's undervalued.

Historical Valuation

TuHURA Biosciences Inc (HURA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -8.25. The fair price of TuHURA Biosciences Inc (HURA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.68

Fair

-5.20

Trailing

Forward

0.00

EV/EBITDA

TuHURA Biosciences Inc. (HURA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

-4.55

EV/EBIT

TuHURA Biosciences Inc. (HURA) has a current EV/EBIT of -4.55. The 5-year average EV/EBIT is -7.66. The thresholds are as follows: Strongly Undervalued below -15.13, Undervalued between -15.13 and -11.40, Fairly Valued between -3.92 and -11.40, Overvalued between -3.92 and -0.18, and Strongly Overvalued above -0.18. The current Forward EV/EBIT of -4.55 falls within the Historic Trend Line -Fairly Valued range.

0.00

TuHURA Biosciences Inc. (HURA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

TuHURA Biosciences Inc. (HURA) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

TuHURA Biosciences Inc. (HURA) has a current P/FCF of 0.00. The 5-year average P/FCF is -6.38. The thresholds are as follows: Strongly Undervalued below -16.43, Undervalued between -16.43 and -11.40, Fairly Valued between -1.36 and -11.40, Overvalued between -1.36 and 3.66, and Strongly Overvalued above 3.66. The current Forward P/FCF of 0.00 falls within the Overvalued range.

TuHURA Biosciences Inc (HURA) has a current Price-to-Book (P/B) ratio of 12.68. Compared to its 3-year average P/B ratio of -70.26 , the current P/B ratio is approximately -118.05% higher. Relative to its 5-year average P/B ratio of -70.26, the current P/B ratio is about -118.05% higher. TuHURA Biosciences Inc (HURA) has a Forward Free Cash Flow (FCF) yield of approximately -11.86%. Compared to its 3-year average FCF yield of -10.04%, the current FCF yield is approximately 18.07% lower. Relative to its 5-year average FCF yield of -10.04% , the current FCF yield is about 18.07% lower.

12.68

P/B

Median3y

-70.26

Median5y

-70.26

-11.86

FCF Yield

Median3y

-10.04

Median5y

-10.04

Competitors Valuation Multiple

The average P/S ratio for HURA's competitors is 29.27, providing a benchmark for relative valuation. TuHURA Biosciences Inc Corp (HURA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

HURA.O

TuHURA Biosciences Inc

Molecular Partners AG

Spero Therapeutics Inc

Lexeo Therapeutics Inc

Loss

136.11M

Performance Decomposition

Market capitalization of HURA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of HURA in the past 1 year is driven by Unknown.